Aflac posted adjusted fourth-quarter earnings of $1.57 per share, missing the Zacks Consensus Estimate of $1.71. This result represents a slight improvement from the prior year’s $1.56 per share but fell 8.2% below the Street forecast. Net investment income grew 4.5% year-over-year, driven by higher yields on fixed-maturity securities, while pre-tax operating earnings were supported by a 3.2% increase in U.S. supplemental health insurance premiums. However, currency headwinds in Japan and elevated claim costs for certain medical products modestly compressed margins. Investors will be watching management’s guidance for 2026 to see if investment spreads and premium growth can offset ongoing foreign exchange volatility.

On February 11, 2026 at 9:40 a.m. ET, Aflac U.S. President Virgil R. Miller will speak in a fireside chat at the UBS Financial Services Conference. The live webcast will be accessible online, with a replay available within 24 hours. Management is expected to elaborate on the company’s strategic priorities, including digital distribution enhancements, expense management initiatives and continued expansion in the Japanese cancer insurance market, where Aflac holds the leading share of policies in force. Analysts will seek clarity on capital return plans and the potential impact of rising global interest rates on the investment portfolio.